No Data
No Data
Express News | TNF Pharmaceuticals Completed FDA-Recommended Study Of Isomyosamine, Demonstrating Clinical Safety Throughout 13 Weeks Of Treatment At All Dose Levels Evaluated
TNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion
Express News | Tnf Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion
TNF Pharmaceuticals, Renova Health Announce Trial to Explore Isomyosamine
Express News | Tnf Pharmaceuticals Inc - Enters Collaborative Agreement With Renova Health
Express News | Tnf: Fully Funded Study to Evaluate Wegovy and Ozempic Patients at Risk for Increased Inflammation Associated With Sarcopenic Muscle Deterioration